SCHEMBL8894870

SCHEMBL8894870

CCOP(=O)(Cl)Oc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
NPSR1 Q6W5P4 1/20 0.47
KCNH2 Q12809 1/20 0.46
SRC P12931 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
CA4 P22748 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
ACHE P22303 2/20 0.43
POLB P06746 1/20 0.43
NR1I2 O75469 1/20 0.42
PKM P14618 1/20 0.42
TP53 P04637 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10566182 1.00 L3MBTL1 (0.50) L3MBTL1NPSR1KCNH2SRCCA1
SCHEMBL8521617 0.94 L3MBTL1 (0.49) L3MBTL1NPSR1KCNH2SRCCA1
SCHEMBL10408346 0.81 CA2 (0.51) L3MBTL1SRCCA1CA2CA12
SCHEMBL122230 0.81 SRC (0.58) L3MBTL1NPSR1SRCTDP1TP53
SCHEMBL23788261 0.80 L3MBTL1 (0.42) L3MBTL1KCNH2SRCTDP1PKM
SCHEMBL124095 0.80 CA1 (0.54) L3MBTL1NPSR1KCNH2SRCCA1
Phosphoric Acid Diethyl Ester Phenyl Ester SCHEMBL133234 0.80 CA1 (0.59) L3MBTL1NPSR1KCNH2SRCCA1
SCHEMBL9463259 0.80 LTA4H (0.46)
Methylene Chloride SCHEMBL29220060 0.79 SRC (0.52) L3MBTL1SRCTDP1MEN1HTT
SCHEMBL8519322 0.79 TSHR (0.53) L3MBTL1SRCTDP1MEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11771688-B2 Pyridine derivatives substituted by heterocyclic ring and amino group AMPLYX PHARMACEUTICALS, INC. (US) 2023-10-03 US disclosed
CN-1882629-A Flame retardant, additive compositions, and flame retardant polyurethanes ALBEMARLE CORP (US) 2006-12-20 CN disclosed
US-5677281-A ADMINISTERING ARALKYLPHOSPHONYL TRIPEPTIDE TO INHIBIT SPECIFIED ENDOPEPTIDASES COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1997-10-14 US disclosed
EP-0278661-A1 A thiophosphoric acid ester as an insecticide, nematocide and acaricide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-08-17 EP disclosed
US-4376064-A OXYGENATED COMPOUND OF PHOSPHORUS STANDARD OIL CO. (INDIANA) (US) 1983-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11771688-B2 Pyridine derivatives substituted by heterocyclic ring and amino group ERG28, PDXK, PAH L3MBTL1 4607/4885NPSR1 3544/4885KCNH2 2924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.